Current and historical daily PS Ratio for Catalyst Pharmaceuticals Inc (
) from 2006 to Jul 21 2026. The price to sales ratio is calculated by taking the current stock price and dividing it by the trailing twelve-month sales per share. The data is updated every 20 minutes during market hours. The PS ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS ratio is a great valuation tool for evaluating cyclical businesses where the PE ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean. Catalyst Pharmaceuticals stock (CPRX) PS ratio as of Jul 21 2026 is 6.71.
More Details
Catalyst Pharmaceuticals Inc (CPRX) PS Ratio Chart
Catalyst Pharmaceuticals Inc (CPRX) PS Ratio Historical Data
View and export this data going back to 2006. Start your Free Trial
Total 1207
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Catalyst Pharmaceuticals PS Ratio Historical Data | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date | PS Ratio Data | Date | PS Ratio Data | ||||||
| 2026-07-21 | 6.7 | 6.7 | 6.7 | 6.7 | 2026-05-14 | 6.6 | 6.63 | 6.63 | 6.63 |
| 2026-07-20 | 6.7 | 6.7 | 6.7 | 6.7 | 2026-05-13 | 6.6 | 6.64 | 6.63 | 6.63 |
| 2026-07-17 | 6.7 | 6.7 | 6.7 | 6.7 | 2026-05-12 | 6.6 | 6.63 | 6.63 | 6.63 |
| 2026-07-16 | 6.7 | 6.7 | 6.7 | 6.7 | 2026-05-11 | 6.6 | 6.64 | 6.63 | 6.63 |
| 2026-07-15 | 6.7 | 6.7 | 6.7 | 6.7 | 2026-05-08 | 6.6 | 6.64 | 6.62 | 6.63 |
| 2026-07-14 | 6.7 | 6.7 | 6.7 | 6.7 | 2026-05-07 | 6.6 | 6.66 | 6.61 | 6.63 |
| 2026-07-13 | 6.7 | 6.7 | 6.7 | 6.7 | 2026-05-06 | 6.6 | 6.64 | 6.42 | 6.49 |
| 2026-07-10 | 6.7 | 6.7 | 6.7 | 6.7 | 2026-05-05 | 6.2 | 6.59 | 6.12 | 6.57 |
| 2026-07-09 | 6.7 | 6.7 | 6.7 | 6.7 | 2026-05-04 | 6.2 | 6.23 | 6.05 | 6.16 |
| 2026-07-08 | 6.7 | 6.7 | 6.69 | 6.7 | 2026-05-01 | 6.0 | 6.13 | 5.99 | 6.11 |
| 2026-07-07 | 6.7 | 6.7 | 6.69 | 6.7 | 2026-04-30 | 6.0 | 6.06 | 5.89 | 5.99 |
| 2026-07-06 | 6.7 | 6.7 | 6.69 | 6.7 | 2026-04-29 | 6.2 | 6.2 | 5.97 | 6.01 |
| 2026-07-02 | 6.7 | 6.7 | 6.69 | 6.69 | 2026-04-28 | 6.3 | 6.44 | 6.09 | 6.26 |
| 2026-07-01 | 6.7 | 6.69 | 6.69 | 6.69 | 2026-04-27 | 5.9 | 6.93 | 5.81 | 6.23 |
| 2026-06-30 | 6.7 | 6.69 | 6.69 | 6.69 | 2026-04-24 | 5.9 | 5.98 | 5.64 | 5.82 |
| 2026-06-29 | 6.7 | 6.7 | 6.69 | 6.69 | 2026-04-23 | 5.5 | 5.9 | 5.51 | 5.89 |
| 2026-06-26 | 6.7 | 6.7 | 6.68 | 6.7 | 2026-04-22 | 5.5 | 5.52 | 5.44 | 5.52 |
| 2026-06-25 | 6.7 | 6.69 | 6.68 | 6.69 | 2026-04-21 | 5.5 | 5.54 | 5.45 | 5.46 |
| 2026-06-24 | 6.7 | 6.69 | 6.68 | 6.69 | 2026-04-20 | 5.6 | 5.62 | 5.51 | 5.55 |
| 2026-06-23 | 6.7 | 6.68 | 6.67 | 6.68 | 2026-04-17 | 5.6 | 5.61 | 5.5 | 5.59 |
| 2026-06-22 | 6.7 | 6.68 | 6.67 | 6.68 | 2026-04-16 | 5.5 | 5.54 | 5.44 | 5.51 |
| 2026-06-18 | 6.7 | 6.68 | 6.67 | 6.68 | 2026-04-15 | 5.6 | 5.57 | 5.45 | 5.5 |
| 2026-06-17 | 6.7 | 6.68 | 6.67 | 6.68 | 2026-04-14 | 5.5 | 5.63 | 5.43 | 5.57 |
| 2026-06-16 | 6.7 | 6.68 | 6.67 | 6.67 | 2026-04-13 | 5.3 | 5.41 | 5.25 | 5.39 |
| 2026-06-15 | 6.7 | 6.67 | 6.67 | 6.67 | 2026-04-10 | 5.4 | 5.44 | 5.28 | 5.31 |
| 2026-06-12 | 6.7 | 6.68 | 6.67 | 6.67 | 2026-04-09 | 5.3 | 5.49 | 5.3 | 5.45 |
| 2026-06-11 | 6.7 | 6.68 | 6.67 | 6.67 | 2026-04-08 | 5.4 | 5.49 | 5.37 | 5.39 |
| 2026-06-10 | 6.7 | 6.67 | 6.67 | 6.67 | 2026-04-07 | 5.3 | 5.35 | 5.28 | 5.32 |
| 2026-06-09 | 6.7 | 6.67 | 6.66 | 6.67 | 2026-04-06 | 5.3 | 5.32 | 5.22 | 5.31 |
| 2026-06-08 | 6.7 | 6.66 | 6.66 | 6.66 | 2026-04-02 | 5.2 | 5.27 | 5.19 | 5.25 |
| 2026-06-05 | 6.7 | 6.66 | 6.65 | 6.65 | 2026-04-01 | 5.3 | 5.35 | 5.24 | 5.28 |
| 2026-06-04 | 6.7 | 6.66 | 6.65 | 6.66 | 2026-03-31 | 5.1 | 5.28 | 5.11 | 5.27 |
| 2026-06-03 | 6.7 | 6.66 | 6.65 | 6.66 | 2026-03-30 | 5.0 | 5.08 | 4.9 | 5.06 |
| 2026-06-02 | 6.7 | 6.66 | 6.65 | 6.65 | 2026-03-27 | 5.2 | 5.25 | 5.05 | 5.05 |
| 2026-06-01 | 6.7 | 6.66 | 6.65 | 6.65 | 2026-03-26 | 5.1 | 5.31 | 5.1 | 5.24 |
| 2026-05-29 | 6.7 | 6.67 | 6.64 | 6.64 | 2026-03-25 | 5.1 | 5.14 | 5.01 | 5.14 |
| 2026-05-28 | 6.7 | 6.66 | 6.66 | 6.66 | 2026-03-24 | 5.0 | 5.04 | 4.95 | 4.98 |
| 2026-05-27 | 6.7 | 6.67 | 6.65 | 6.66 | 2026-03-23 | 5.0 | 5.12 | 4.98 | 5.04 |
| 2026-05-26 | 6.7 | 6.67 | 6.65 | 6.67 | 2026-03-20 | 4.8 | 4.94 | 4.79 | 4.92 |
| 2026-05-22 | 6.7 | 6.66 | 6.65 | 6.65 | 2026-03-19 | 4.9 | 4.91 | 4.79 | 4.82 |
| 2026-05-21 | 6.6 | 6.67 | 6.64 | 6.66 | 2026-03-18 | 5.0 | 5.04 | 4.87 | 4.93 |
| 2026-05-20 | 6.6 | 6.65 | 6.64 | 6.65 | 2026-03-17 | 5.0 | 5.09 | 5.02 | 5.04 |
| 2026-05-19 | 6.6 | 6.65 | 6.64 | 6.64 | 2026-03-16 | 5.0 | 5.09 | 5.01 | 5.03 |
| 2026-05-18 | 6.6 | 6.65 | 6.63 | 6.64 | 2026-03-13 | 5.1 | 5.08 | 4.93 | 5.02 |
| 2026-05-15 | 6.6 | 6.63 | 6.62 | 6.63 | 2026-03-12 | 5.2 | 5.18 | 5.05 | 5.05 |
Catalyst Pharmaceuticals Inc (CPRX) PS Ratio Comparison
| Company | Market Cap(Mil) | PS Ratio |
|---|
Business Description
Business Description
Catalyst Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US14888U1016
Total Employee Number:
182Description
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers